Skip to main content
Erschienen in: Tumor Biology 4/2012

01.08.2012 | Research Article

Tumor microsomal metabolism of the food toxicant, benzo(a)pyrene, in ApcMin mouse model of colon cancer

verfasst von: Deacqunita L. Diggs, Kelly L. Harris, Perumalla V. Rekhadevi, Aramandla Ramesh

Erschienen in: Tumor Biology | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

The present study was conducted to investigate whether colon tumors were capable of metabolizing benzo(a)pyrene (BaP), and fluoranthene (FLA), two toxicants that belong to the polycyclic aromatic hydrocarbon family of compounds. Microsomes were isolated from the colon tumors of ApcMin mice that received subchronic doses of 50 μg/kg BaP and incubated with either BaP or FLA (3 μM each) alone or in combination and appropriate control groups that received nothing. Subsequent to incubation, samples were extracted with ethyl acetate and analyzed for BaP and FLA metabolites by reverse-phase HPLC equipped with fluorescence detection. Microsomes from tumor tissues were found to metabolize BaP to a greater extent than those from the non-tumor tissues. The rate of BaP metabolism (picomoles of metabolite per minute per milligram of protein) was found to be more when microsomes from BaP-pretreated mice were exposed to BaP alone and FLA in combination with BaP, compared to controls. The microsomes from BaP-preexposed mice generated greater proportion of BaP 7,8-diol and BaP 3,6- and 6,12-diones compared to other experimental groups. Additionally, microsomes from BaP-pretreated mice produced greater proportion of FLA 2, 3-diol and 2, 3 D FLA when microsomes were incubated with FLA alone or a combination of BaP and FLA. Our studies revealed that the tumor microsomes were competent to metabolize BaP and FLA either singly or in combination. The biotransformation of BaP and FLA as a consequence of prior and simultaneous exposure to BaP may influence the growth of tumors. Our findings may have relevance to human long-term dietary intake of these toxicants and the consequent acceleration of the colon carcinogenesis process.
Literatur
1.
Zurück zum Zitat Whitlock EP, Lin JS, Liles E, et al. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:638–58.PubMed Whitlock EP, Lin JS, Liles E, et al. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:638–58.PubMed
2.
Zurück zum Zitat Diggs DL, Huderson AC, Harris KL, Myers JN, Banks LD, Rekhadevi PV, et al. Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2011;29:324–57.PubMedPubMedCentral Diggs DL, Huderson AC, Harris KL, Myers JN, Banks LD, Rekhadevi PV, et al. Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2011;29:324–57.PubMedPubMedCentral
3.
Zurück zum Zitat Laconi E. The evolving concept of tumor microenvironments. Bioessays. 2007;29:738–44.PubMed Laconi E. The evolving concept of tumor microenvironments. Bioessays. 2007;29:738–44.PubMed
4.
Zurück zum Zitat Mellor HR, Snelling S, Hall MD, Modok S, Jaffar M, Hambley TW, et al. The influence of tumour microenvironmental factors on the efficacy of cisplatin and novel platinum(IV) complexes. Biochem Pharmacol. 2005;70:1137–46.PubMed Mellor HR, Snelling S, Hall MD, Modok S, Jaffar M, Hambley TW, et al. The influence of tumour microenvironmental factors on the efficacy of cisplatin and novel platinum(IV) complexes. Biochem Pharmacol. 2005;70:1137–46.PubMed
5.
Zurück zum Zitat Augsten M, Hägglöf C, Peña C, Ostman A. A digest on the role of the tumor microenvironment in gastrointestinal cancers. Cancer Microenviron. 2010;3:167–76.PubMedPubMedCentral Augsten M, Hägglöf C, Peña C, Ostman A. A digest on the role of the tumor microenvironment in gastrointestinal cancers. Cancer Microenviron. 2010;3:167–76.PubMedPubMedCentral
6.
Zurück zum Zitat Fischer AH, Young KA, DoLollis RA. Incorporating pathologists criteria of malignancy into the evolutionary model for cancer development. J Cell Biochem. 2004;93:28–36.PubMed Fischer AH, Young KA, DoLollis RA. Incorporating pathologists criteria of malignancy into the evolutionary model for cancer development. J Cell Biochem. 2004;93:28–36.PubMed
7.
Zurück zum Zitat Sonnenschein C, Soto A. Carcinogenesis and metastasis now in the third dimension—what's in for the pathologists? Am J Pathol. 2006;168:363–6.PubMedPubMedCentral Sonnenschein C, Soto A. Carcinogenesis and metastasis now in the third dimension—what's in for the pathologists? Am J Pathol. 2006;168:363–6.PubMedPubMedCentral
8.
Zurück zum Zitat Peddareddigari VG, Wang D, DuBois RN. The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron. 2010;3:149–66.PubMedPubMedCentral Peddareddigari VG, Wang D, DuBois RN. The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron. 2010;3:149–66.PubMedPubMedCentral
9.
Zurück zum Zitat Rochat B, Morsman JM, Murray GI, Figg WD, McLeod HL. Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation? J Pharmacol Exp Ther. 2001;296:537–41.PubMed Rochat B, Morsman JM, Murray GI, Figg WD, McLeod HL. Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation? J Pharmacol Exp Ther. 2001;296:537–41.PubMed
10.
Zurück zum Zitat Mérida I, Ávila-Flores A. Tumor metabolism: new opportunities for cancer therapy. Clin Transl Oncol. 2006;8:711–6.PubMed Mérida I, Ávila-Flores A. Tumor metabolism: new opportunities for cancer therapy. Clin Transl Oncol. 2006;8:711–6.PubMed
11.
Zurück zum Zitat Lunt SJ, Chaudary N, Hill RP. The tumor microenvironment and metastatic disease. Clin Exp Metastasis. 2009;26:19–34.PubMed Lunt SJ, Chaudary N, Hill RP. The tumor microenvironment and metastatic disease. Clin Exp Metastasis. 2009;26:19–34.PubMed
12.
Zurück zum Zitat Knuckles ME, Inyang F, Ramesh A. Acute and subchronic oral toxicity of benzo(a)pyrene in F-344 rats. Toxicol Sci. 2001;61:382–8.PubMed Knuckles ME, Inyang F, Ramesh A. Acute and subchronic oral toxicity of benzo(a)pyrene in F-344 rats. Toxicol Sci. 2001;61:382–8.PubMed
13.
Zurück zum Zitat Luch A. The carcinogenic effects of polycyclic aromatic hydrocarbons. London: Imperial College Press Eds; 2005. Luch A. The carcinogenic effects of polycyclic aromatic hydrocarbons. London: Imperial College Press Eds; 2005.
14.
Zurück zum Zitat WHO. Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Vol. 92. Lyon, France: International Agency for Research on Cancer; 2010. WHO. Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Vol. 92. Lyon, France: International Agency for Research on Cancer; 2010.
15.
Zurück zum Zitat Ramesh A, Archibong A, Hood DB, Guo Z, Loganathan BG. Global environmental distribution and human health effects of polycyclic aromatic hydrocarbons. In: Lam PKS, Loganathan BG, editors. Global contamination trends of persistent organic chemicals. Boca Raton: Taylor & Francis; 2011. p. 95–124. Ramesh A, Archibong A, Hood DB, Guo Z, Loganathan BG. Global environmental distribution and human health effects of polycyclic aromatic hydrocarbons. In: Lam PKS, Loganathan BG, editors. Global contamination trends of persistent organic chemicals. Boca Raton: Taylor & Francis; 2011. p. 95–124.
16.
Zurück zum Zitat Sinha R, Kulldorff M, Gunter MJ, Strickland P, Rothman N. Dietary benzo(a)pyrene intake and risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2005;14:2030–4.PubMed Sinha R, Kulldorff M, Gunter MJ, Strickland P, Rothman N. Dietary benzo(a)pyrene intake and risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2005;14:2030–4.PubMed
17.
Zurück zum Zitat Gunter MJ, Probst-Hensch NM, Cortessis VK, Kulldorff M, Haile RW, Sinha R. Meat intake, cooking-related mutagens and risk of colorectal adenoma in a sigmoidoscopy-based case–control study. Carcinogenesis. 2005;26:637–42.PubMed Gunter MJ, Probst-Hensch NM, Cortessis VK, Kulldorff M, Haile RW, Sinha R. Meat intake, cooking-related mutagens and risk of colorectal adenoma in a sigmoidoscopy-based case–control study. Carcinogenesis. 2005;26:637–42.PubMed
18.
Zurück zum Zitat Knuckles ME, Inyang F, Ramesh A. Acute and subchronic oral toxicity of fluoranthene in F-344 rats. Ecotoxicol Environ Saf. 2004;59:102–8.PubMed Knuckles ME, Inyang F, Ramesh A. Acute and subchronic oral toxicity of fluoranthene in F-344 rats. Ecotoxicol Environ Saf. 2004;59:102–8.PubMed
19.
Zurück zum Zitat Walker SA, Addai AB, Mathis M, Ramesh A. Effect of dietary fat on metabolism and DNA adduct formation after acute oral exposure of F-344 rats to fluoranthene. J Nutr Biochem. 2007;18:236–49.PubMed Walker SA, Addai AB, Mathis M, Ramesh A. Effect of dietary fat on metabolism and DNA adduct formation after acute oral exposure of F-344 rats to fluoranthene. J Nutr Biochem. 2007;18:236–49.PubMed
20.
Zurück zum Zitat Ramesh A, Walker SA, Hood DB, Guillén MD, Schneider K, Weyand EH. Bioavailability and risk assessment of orally ingested polycyclic aromatic hydrocarbons. Int J Toxicol. 2004;23:301–33.PubMed Ramesh A, Walker SA, Hood DB, Guillén MD, Schneider K, Weyand EH. Bioavailability and risk assessment of orally ingested polycyclic aromatic hydrocarbons. Int J Toxicol. 2004;23:301–33.PubMed
21.
Zurück zum Zitat Lobscheid AB, Maddalena RL, McKone TE. Contribution of locally grown foods in cumulative exposure assessments. J Expo Anal Environ Epidemiol. 2004;14:60–73.PubMed Lobscheid AB, Maddalena RL, McKone TE. Contribution of locally grown foods in cumulative exposure assessments. J Expo Anal Environ Epidemiol. 2004;14:60–73.PubMed
22.
Zurück zum Zitat National Research Council [NRC]. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press; 1996. National Research Council [NRC]. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press; 1996.
23.
Zurück zum Zitat Ramesh A, Inyang F, Hood DB, Archibong AE, Knuckles ME, Nyanda AM. Metabolism, bioavailability, and toxicokinetics of benzo(a)pyrene in F344 rats following oral administration. Exp Toxic Pathol. 2001;53:275–90. Ramesh A, Inyang F, Hood DB, Archibong AE, Knuckles ME, Nyanda AM. Metabolism, bioavailability, and toxicokinetics of benzo(a)pyrene in F344 rats following oral administration. Exp Toxic Pathol. 2001;53:275–90.
24.
Zurück zum Zitat Walker SA, Whitten LB, Seals GB, Lee WE, Archibong AE, Ramesh A. Interspecies comparison of liver and small intestinal microsomal metabolism of fluoranthene. Food Chem Toxicol. 2006;44:380–7.PubMed Walker SA, Whitten LB, Seals GB, Lee WE, Archibong AE, Ramesh A. Interspecies comparison of liver and small intestinal microsomal metabolism of fluoranthene. Food Chem Toxicol. 2006;44:380–7.PubMed
25.
Zurück zum Zitat NIH. Guidelines for the laboratory use of chemical carcinogens. National Institutes of Health, US Government Printing Office, NIH Publication No. 81–2385. Washington, DC; 1981. NIH. Guidelines for the laboratory use of chemical carcinogens. National Institutes of Health, US Government Printing Office, NIH Publication No. 81–2385. Washington, DC; 1981.
26.
Zurück zum Zitat Massaad L, de Waziers I, Ribrag V, Janot F, Beaune PH, Morizet J, et al. Comparison of mouse and human colon tumors with regard to phase I and phase II drug metabolizing enzyme systems. Cancer Res. 1992;52:6567–75.PubMed Massaad L, de Waziers I, Ribrag V, Janot F, Beaune PH, Morizet J, et al. Comparison of mouse and human colon tumors with regard to phase I and phase II drug metabolizing enzyme systems. Cancer Res. 1992;52:6567–75.PubMed
27.
Zurück zum Zitat Halberg RB, Larsen MC, Elmergreen TL, Ko AY, Irving AA, Clipson L, et al. Cyp1b1 exerts opposing effects on intestinal tumorigenesis via exogenous and endogenous substrates. Cancer Res. 2008;68:7394–402.PubMedPubMedCentral Halberg RB, Larsen MC, Elmergreen TL, Ko AY, Irving AA, Clipson L, et al. Cyp1b1 exerts opposing effects on intestinal tumorigenesis via exogenous and endogenous substrates. Cancer Res. 2008;68:7394–402.PubMedPubMedCentral
28.
Zurück zum Zitat Uno S, Dragin N, Miller ML, Dalton TP, Gonzalez FJ, Nebert DW. Basal and inducible Cyp1 mRNA quantitation and protein localization throughout the mouse gastrointestinal tract. Free Radic Biol Med. 2008;44:570–83.PubMed Uno S, Dragin N, Miller ML, Dalton TP, Gonzalez FJ, Nebert DW. Basal and inducible Cyp1 mRNA quantitation and protein localization throughout the mouse gastrointestinal tract. Free Radic Biol Med. 2008;44:570–83.PubMed
29.
Zurück zum Zitat Sattar A, Hewer A, Phillips DH, Campbell FC. Metabolic proficiency and benzo(a)pyrene DNA adduct formation in ApcMin mouse adenomas and uninvolved mucosa. Carcinogenesis. 1999;20:1097–101.PubMed Sattar A, Hewer A, Phillips DH, Campbell FC. Metabolic proficiency and benzo(a)pyrene DNA adduct formation in ApcMin mouse adenomas and uninvolved mucosa. Carcinogenesis. 1999;20:1097–101.PubMed
30.
Zurück zum Zitat Vaca C, Tornquist M, Rannug U, Lindahl-Kiessling K, Ahnstrom G, Ehrenberg L. On the bioactivation and genotoxic action of fluoranthene. Arch Toxicol. 1992;66:538–45.PubMed Vaca C, Tornquist M, Rannug U, Lindahl-Kiessling K, Ahnstrom G, Ehrenberg L. On the bioactivation and genotoxic action of fluoranthene. Arch Toxicol. 1992;66:538–45.PubMed
31.
Zurück zum Zitat Huderson AC, Harris DL, Niaz MS, Ramesh A. Effect of benzo(a)pyrene exposure on fluoranthene metabolism by mouse adipose tissue microsomes. Toxicol Mech Methods. 2010;20:53–8.PubMedPubMedCentral Huderson AC, Harris DL, Niaz MS, Ramesh A. Effect of benzo(a)pyrene exposure on fluoranthene metabolism by mouse adipose tissue microsomes. Toxicol Mech Methods. 2010;20:53–8.PubMedPubMedCentral
32.
Zurück zum Zitat Buesen R, Mock M, Seidel A, Jacob J, Lampen A. Interaction between metabolism and transport of benzo[a]pyrene and its metabolites in enterocytes. Toxicol Appl Pharmacol. 2002;183:168–78.PubMed Buesen R, Mock M, Seidel A, Jacob J, Lampen A. Interaction between metabolism and transport of benzo[a]pyrene and its metabolites in enterocytes. Toxicol Appl Pharmacol. 2002;183:168–78.PubMed
33.
Zurück zum Zitat Myers JN, Rekhadevi PV, Ramesh A. Comparative evaluation of different cell lysis and extraction methods for studying benzo(a)pyrene metabolism in HT-29 colon cancer cell cultures. Cell Physiol Biochem. 2011;28:209–18.PubMedPubMedCentral Myers JN, Rekhadevi PV, Ramesh A. Comparative evaluation of different cell lysis and extraction methods for studying benzo(a)pyrene metabolism in HT-29 colon cancer cell cultures. Cell Physiol Biochem. 2011;28:209–18.PubMedPubMedCentral
34.
Zurück zum Zitat Uno S, Makishima M. Benzo(a)pyrene toxicity and inflammatory disease. Curr Rheumatol Rev. 2009;5:266–71. Uno S, Makishima M. Benzo(a)pyrene toxicity and inflammatory disease. Curr Rheumatol Rev. 2009;5:266–71.
35.
Zurück zum Zitat Khalil A, Villard PH, Dao MA, Burcelin R, Champion S, Fouchier F, et al. Polycyclic aromatic hydrocarbons potentiate high-fat diet effects on intestinal inflammation. Toxicol Lett. 2010;196:161–7.PubMed Khalil A, Villard PH, Dao MA, Burcelin R, Champion S, Fouchier F, et al. Polycyclic aromatic hydrocarbons potentiate high-fat diet effects on intestinal inflammation. Toxicol Lett. 2010;196:161–7.PubMed
36.
Zurück zum Zitat Weston A, Harris CC. Chemical carcinogenesis. In: Holland-Frei Cancer Medicine. 5th edn. Hamilton, Ontario; 2000. Weston A, Harris CC. Chemical carcinogenesis. In: Holland-Frei Cancer Medicine. 5th edn. Hamilton, Ontario; 2000.
37.
Zurück zum Zitat Chen JK, Wu ZL, Liu YG, Lei YX. Effects of metabolites of benzo(a)pyrene on unscheduled DNA synthesis in BALB/3T3 cell line. Chemosphere. 2000;41:139–42.PubMed Chen JK, Wu ZL, Liu YG, Lei YX. Effects of metabolites of benzo(a)pyrene on unscheduled DNA synthesis in BALB/3T3 cell line. Chemosphere. 2000;41:139–42.PubMed
38.
Zurück zum Zitat Piskorska-Pliszczynska J, Keys B, Safe S, Newman MS. The cytosolic receptor binding affinities and AHH induction potencies of 29 polynuclear aromatic hydrocarbons. Toxicol Lett. 1986;34:67–74.PubMed Piskorska-Pliszczynska J, Keys B, Safe S, Newman MS. The cytosolic receptor binding affinities and AHH induction potencies of 29 polynuclear aromatic hydrocarbons. Toxicol Lett. 1986;34:67–74.PubMed
39.
Zurück zum Zitat Willett KL, Gardinali PR, Sericano JL, Wade TL, Safe SH. Characterization of the rat hepatoma cell bioassay for evaluation of environmental samples containing polynuclear aromatic hydrocarbons (PAHs). Arch Environ Contam Toxicol. 1997;32:442–8.PubMed Willett KL, Gardinali PR, Sericano JL, Wade TL, Safe SH. Characterization of the rat hepatoma cell bioassay for evaluation of environmental samples containing polynuclear aromatic hydrocarbons (PAHs). Arch Environ Contam Toxicol. 1997;32:442–8.PubMed
40.
Zurück zum Zitat Warshawsky D, Barkley W, Bingham E. Factors affecting carcinogenic potential of mixtures. Fundam Appl Toxicol. 1993;20:376–82.PubMed Warshawsky D, Barkley W, Bingham E. Factors affecting carcinogenic potential of mixtures. Fundam Appl Toxicol. 1993;20:376–82.PubMed
41.
Zurück zum Zitat Babson JR, Russo-Rodriguez S, Rastetter WH, Wogan GN. Invitro DNA-binding of microsomally-activated fluoranthene: evidence that the major product is a fluoranthene N2—deoxyguanosine adduct. Carcinogenesis. 1986;7:859–65.PubMed Babson JR, Russo-Rodriguez S, Rastetter WH, Wogan GN. Invitro DNA-binding of microsomally-activated fluoranthene: evidence that the major product is a fluoranthene N2—deoxyguanosine adduct. Carcinogenesis. 1986;7:859–65.PubMed
42.
Zurück zum Zitat Hutchins DA, Skipper PL, Naylor S, Tannenbaum SR. Isolation and characterization of the major fluoranthene-hemoglobin adducts formed in vivo in the rat. Cancer Res. 1988;48:4756–61.PubMed Hutchins DA, Skipper PL, Naylor S, Tannenbaum SR. Isolation and characterization of the major fluoranthene-hemoglobin adducts formed in vivo in the rat. Cancer Res. 1988;48:4756–61.PubMed
43.
Zurück zum Zitat Hursting SD, Slaga TJ, Fischer SM, DiGiovanni J, Phang JM. Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. J Natl Cancer Inst. 1999;91:215–20.PubMed Hursting SD, Slaga TJ, Fischer SM, DiGiovanni J, Phang JM. Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. J Natl Cancer Inst. 1999;91:215–20.PubMed
44.
Zurück zum Zitat Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol. 2010;38:96–109.PubMed Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol. 2010;38:96–109.PubMed
45.
Zurück zum Zitat Harris DL, Washington MK, Hood DB, Roberts II LJ, Ramesh A. Dietary fat-influenced development of colon neoplasia in ApcMin mouse exposed to benzo(a)pyrene. Toxicol Pathol. 2009;37:938–46.PubMedPubMedCentral Harris DL, Washington MK, Hood DB, Roberts II LJ, Ramesh A. Dietary fat-influenced development of colon neoplasia in ApcMin mouse exposed to benzo(a)pyrene. Toxicol Pathol. 2009;37:938–46.PubMedPubMedCentral
46.
Zurück zum Zitat Hakura A, Seki Y, Sonoda J, Hosokawa S, Aoki T, Suganuma A, et al. Rapid induction of colonic adenocarcinoma in mice exposed to benzo[a]pyrene and dextran sulfate sodium. Food Chem Toxicol. 2011;49:2997–3001.PubMed Hakura A, Seki Y, Sonoda J, Hosokawa S, Aoki T, Suganuma A, et al. Rapid induction of colonic adenocarcinoma in mice exposed to benzo[a]pyrene and dextran sulfate sodium. Food Chem Toxicol. 2011;49:2997–3001.PubMed
47.
Zurück zum Zitat Culp SJ, Gaylor DW, Sheldon WG, Goldstein LS, Beland FA. A comparison tar and benzo(a)pyrene in a 2-year bioassay. Carcinogenesis. 1998;19:117–24.PubMed Culp SJ, Gaylor DW, Sheldon WG, Goldstein LS, Beland FA. A comparison tar and benzo(a)pyrene in a 2-year bioassay. Carcinogenesis. 1998;19:117–24.PubMed
48.
Zurück zum Zitat Oshima H, Oshima M. The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models. J Gastroenterol. 2012 (in press). Oshima H, Oshima M. The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models. J Gastroenterol. 2012 (in press).
49.
Zurück zum Zitat Pan MH, Lai CS, Wu JC, Ho CT. Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds. Mol Nutr Food Res. 2011;55:32–45.PubMed Pan MH, Lai CS, Wu JC, Ho CT. Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds. Mol Nutr Food Res. 2011;55:32–45.PubMed
Metadaten
Titel
Tumor microsomal metabolism of the food toxicant, benzo(a)pyrene, in ApcMin mouse model of colon cancer
verfasst von
Deacqunita L. Diggs
Kelly L. Harris
Perumalla V. Rekhadevi
Aramandla Ramesh
Publikationsdatum
01.08.2012
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 4/2012
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-012-0375-6

Weitere Artikel der Ausgabe 4/2012

Tumor Biology 4/2012 Zur Ausgabe

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.